Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial.

Badve SV, Al Ammari M, Anderson CS, Billot L, Bompoint S, Collister D, De Vriese AS, Eikelboom JW, Flahault A, Garg AX, Ha JT, Heerspink HJL, Jardine MJ, Jesudason S, Jha V, Jun M, Landrigan J, Liew A, Lin E, Lv J, Mark PB, Menne J, Monaghan H, Mushahar L, Patel A, Pilmore H, Perkovic V, Ramachandran R, Rossignol P, Shaman A, Skhiri H, Walsh M, Wheeler DC, Wong MG, Zuo L, Gallagher M

Open source

DOI: 10.1159/000550796
Published: 2026 Feb 9
Container: American journal of nephrology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1159/000550796,
  title = {Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial.},
  author = {Badve SV and Al Ammari M and Anderson CS and Billot L and Bompoint S and Collister D and De Vriese AS and Eikelboom JW and Flahault A and Garg AX and Ha JT and Heerspink HJL and Jardine MJ and Jesudason S and Jha V and Jun M and Landrigan J and Liew A and Lin E and Lv J and Mark PB and Menne J and Monaghan H and Mushahar L and Patel A and Pilmore H and Perkovic V and Ramachandran R and Rossignol P and Shaman A and Skhiri H and Walsh M and Wheeler DC and Wong MG and Zuo L and Gallagher M},
  year = {2026},
  journal = {American journal of nephrology},
  doi = {10.1159/000550796},
  url = {https://doi.org/10.1159/000550796}
}

RIS

TY  - JOUR
TI  - Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial.
AU  - Badve SV
AU  - Al Ammari M
AU  - Anderson CS
AU  - Billot L
AU  - Bompoint S
AU  - Collister D
AU  - De Vriese AS
AU  - Eikelboom JW
AU  - Flahault A
AU  - Garg AX
AU  - Ha JT
AU  - Heerspink HJL
AU  - Jardine MJ
AU  - Jesudason S
AU  - Jha V
AU  - Jun M
AU  - Landrigan J
AU  - Liew A
AU  - Lin E
AU  - Lv J
AU  - Mark PB
AU  - Menne J
AU  - Monaghan H
AU  - Mushahar L
AU  - Patel A
AU  - Pilmore H
AU  - Perkovic V
AU  - Ramachandran R
AU  - Rossignol P
AU  - Shaman A
AU  - Skhiri H
AU  - Walsh M
AU  - Wheeler DC
AU  - Wong MG
AU  - Zuo L
AU  - Gallagher M
PY  - 2026
JO  - American journal of nephrology
DO  - 10.1159/000550796
UR  - https://doi.org/10.1159/000550796
ER  -

APA

SV, B., M, A. A., CS, A., L, B., S, B., D, C., AS, D. V., JW, E., A, F., AX, G., JT, H., HJL, H., MJ, J., S, J., V, J., M, J., J, L., A, L., E, L., J, L., PB, M., J, M., H, M., L, M., A, P., H, P., V, P., R, R., P, R., A, S., H, S., M, W., DC, W., MG, W., L, Z., & M, G. (2026). Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial.. American journal of nephrology. https://doi.org/10.1159/000550796

Source records

pubmed · retrieved 2026-09-26T10:26:49.040Z
europe-pmc · retrieved 2026-09-26T10:26:49.049Z
hal · retrieved 2026-09-26T10:26:49.087Z